期刊文献+

乙型肝炎病毒X蛋白稳定表达株的构建及沉默效果观察

Construction of HepG2-HBX cell strain and validation of the silencing effect of siHBX
下载PDF
导出
摘要 目的构建稳定表达乙型肝炎病毒X蛋白(HBX)基因的HepG2-HBX细胞系,观察小分子干扰RNA(siRNA)对HBX基因的特异性抑制效果。方法用脂质体将含有HBX序列的真核表达质粒pCDNA3.1(+)/HBX-Flag转染入HepG2细胞系,通过G418筛选后,分别经RT-PCR和免疫组化对HBX的表达进行验证;化学合成靶向HBX的siRNA(即siHBX),转染入HBX稳定表达株,分别以RT-PCR和实时荧光定量RT-PCR检测HBX mRNA表达水平,Western blot检测HBX蛋白表达水平以验证siHBX对HBX基因的沉默效应,流式细胞仪检测细胞周期变化。结果成功构建表达HBX基因的HepG2-HBX细胞系;siHBX可以高效特异抑制HBX表达,并抑制细胞周期进展。结论 siHBX可作为一种靶向抑制肝癌细胞系内HBX表达的策略,为后续HBV感染相关性肝癌的治疗奠定了实验基础。 Objective To construct the HepG2-HBX cell strain that stably expressing the hepatitis B virus protein X(HBX) and to explore the specific silencing effect of siRNA on the HBX gene.Methods The pCDNA3.1(+)/HBX-Flag plasmid containing the HBX sequence was transfected into the HepG2 cell lines with lipofectamine 2000,and the HepG2-HBX cell line stably expressing the HBX gene was screened out with G418;RT-PCR and immunohistochemistry were employed to validate the expression of the HBX gene;the siHBX fragment targeting the HBX gene was chemically synthesized and transfected in to the HepG2-HBX cell line,and RT-PCR,real time quantitative RT-PCR and Western blot were respectively performed to evaluate the the expression of HBX at both the mRNA and protein level.The cell cycle of HBX19 was examined by flow cytometry.Results The HepG2-HBX cell strain stably expressing the HBX gene was successfully constructed and the siHBX fragment may specifically inhibit HBX expression and cell cycle progression.Conclusion siHBX is a potential targeted strategy to inhibit the HBX gene in liver cancer cells.
出处 《基础医学与临床》 CSCD 北大核心 2011年第4期377-382,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(30973378 81071621 30972582) 重庆市科委项目(2009BB5276 2009BB5257)
关键词 乙型肝炎病毒X蛋白 肝癌 小分子干扰RNA 稳定表达 HBX HCC siRNA stable expression
  • 相关文献

参考文献9

  • 1Park IY, Sohn BH, YU E, et al. Aberrant epigenetic modi- fications in hepatocarcinogenesis induced by hepatitis B vi- rus X protein [ J]. Gastroenterology, 2007, 132:1476 - 1479.
  • 2Tang H, Oishi N, Kaneko S, et al. Molecular function and biological roles of hepatitis B virus X protein [ J ]. Cancer Sci, 2006, 97:977-998.
  • 3Zhang F, Wang Q, Ye L, et al. upregulates expression of ealpain factor-kappaB/p65 in hepatoma 2010,82 : 920 - 928. Hepatitis B virus X protein small subunit 1 via nuclear cells [ J]. J Med Virol,.
  • 4Jiao J, Cao H, Chen XW,et al. Downregulation of HBX mRNA in HepG2.2.15 cells by small interfering RNA [ J ]. Eur J Gastroenterol Hepato1,2007,19 : 1114 - 1118.
  • 5Pfaffl MW. A new mathematical model for relative quantifi- cation in real-time RT-PCR [ J ]. Nucleic Acids Res, 2001 , 29 : e45. PMID : 11328886. DOI : 10. 1093/nar/29.9. e45.
  • 6Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference [ J ]. Nature, 2004, 431: 371 - 378.
  • 7刘晓红,林静,曹晓哲,郑建明,陈颖,朱明华.乙型肝炎病毒X蛋白羧基端氨基酸缺失对肝癌细胞生物学行为的影响[J].中华医学杂志,2005,85(12):825-830. 被引量:13
  • 8Xin XM, Li GQ, Guan XR, et al. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell [ J ]. Hepatogastroenterology, 2008, 55:2178 -2183.
  • 9Grimm D, Streetz KL, Jopling CL, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways[J]. Nature, 2006, 441:537-541.

二级参考文献13

  • 1林静,朱明华,曲建慧,李芳梅,倪灿荣.乙型肝炎病毒X基因经p53依赖性与非依赖性途径对p21^(WAF1)表达的影响[J].癌症,2004,23(7):749-755. 被引量:9
  • 2Birrer RB, Birrer D, Klavins JV. Hepatocellular carcinoma and hepatitis virus. Ann Clin Lab Sci, 2003, 33:39-54.
  • 3Tu H, Bonura C, Giannini C,et al. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res, 2001, 61: 7803-7810.
  • 4Sirma H, Giannini C, Poussin K, et al. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene,1999,18:4848-4859.
  • 5Iavarone M, Trabut JB, Delpuech O, et al. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol, 2003, 39: 253-261.
  • 6Murakami S, Cheong JH, Kaneko S. Human hepatitis B virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem,1994,269:15118-15123.
  • 7Elmore LW, Hancock AR, Chang SF, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A, 1997, 94:14707-14712.
  • 8Feitelson MA, Clayton MM. X antigen/antibody markers in hepadnavirus infections. Antibodies to the X gene product(s).Gastroenterology, 1990, 99: 500-507.
  • 9Shih WL, Kuo ML, Chuang SE, et al. Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem, 2000, 275: 25858-25864.
  • 10Schuster R, Gerlich WH, Schaefer S. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene, 2000, 19:1173-1180.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部